Breaking News
Za Pharmacy
Drugs, Supplies and Delivery
Hyoscine (Scopolamine)
Hyoscine’s dual formulations allow targeted therapy for GI spasms and motion sickness, but its use requires careful selection to minimize CNS effects. Adhere to BNF guidelines for dosing, monitor for anticholinergic side effects, and avoid contraindicated conditions.
Hyoscine (scopolamine) is a competitive antagonist of muscarinic acetylcholine receptors, blocking parasympathetic nervous system activity. Its effects depend on the formulation:
- Hyoscine Hydrobromide: Crosses the blood-brain barrier, exerting central and peripheral anticholinergic effects.
- Hyoscine Butylbromide: Primarily acts peripherally with minimal CNS penetration.
By inhibiting acetylcholine binding, hyoscine:
- Reduces smooth muscle spasms in the gastrointestinal (GI) tract.
- Decreases salivary, bronchial, and gastric secretions.
- Suppresses vestibular input to the brain, preventing motion sickness.
Hyoscine is used for:
- Gastrointestinal Spasms:
- Irritable bowel syndrome (IBS), diverticulitis, and colicky pain (hyoscine butylbromide).
- Motion Sickness:
- Prophylaxis via transdermal patch (hyoscine hydrobromide).
- Preoperative/Postoperative Care:
- Reduces salivary and respiratory secretions.
- Palliative Care:
Manages excessive respiratory tract secretions
Adults:
- Hyoscine Butylbromide (GI Spasms): 10–20 mg orally 3–4 times daily (BNF).
- Hyoscine Hydrobromide (Motion Sickness):
- Transdermal Patch: Apply 1 patch (1 mg) behind the ear 5–6 hours before travel; replace every 72 hours.
- Oral: 300–600 mcg 30 minutes before travel (max 1.2 mg/day).
Children:
- Motion Sickness (≥10 years): 150–300 mcg orally (BNF).
- Transdermal Patch: Not recommended for children <12 years.
Special Populations:
- Renal/Hepatic Impairment: Use with caution; reduce dose if necessary.
- Elderly: Increased sensitivity to CNS effects (e.g., confusion).
- Common: Dry mouth, blurred vision, drowsiness, constipation.
- Serious:
- Central Effects (hydrobromide): Confusion, hallucinations, delirium.
- Tachycardia, urinary retention, angle-closure glaucoma.
- Skin Reactions: Itching or erythema under transdermal patch.
- Contraindications:
- Angle-closure glaucoma, myasthenia gravis, intestinal obstruction.
- Severe ulcerative colitis (BNF).
- Pregnancy/Lactation:
- Category C: Avoid unless benefits outweigh risks.
- Excreted in breast milk; may inhibit lactation.
- Elderly: Higher risk of cognitive impairment; avoid prolonged use.
- Anticholinergics (e.g., tricyclic antidepressants): Additive effects (increased dry mouth, urinary retention).
- CNS Depressants (e.g., alcohol, benzodiazepines): Enhanced sedation.
- MAO Inhibitors: Potentiate anticholinergic toxicity.
- Prokinetic Agents (e.g., metoclopramide): Reduced efficacy.
- Hyoscine Hydrobromide:
- Generic: Scopolamine.
- Brand Names: Scopoderm® (patch), Kwells® (oral).
- Hyoscine Butylbromide:
- Generic: Hyoscine butylbromide.
- Brand Names: Buscopan® (oral/injection).
